Log in

Theralase Technologies Inc. (TLT.V) Stock Forecast, Price & News

0.00 (0.00 %)
(As of 11/27/2020 01:43 PM ET)
Today's Range
Now: C$0.19
50-Day Range
MA: C$0.15
52-Week Range
Now: C$0.19
Volume199,603 shs
Average Volume370,764 shs
Market CapitalizationC$38.81 million
P/E RatioN/A
Dividend Yield2.03%
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer in Canada, the United States, and internationally. The company also designs, develops, manufactures, and commercializes medical laser systems and other technologies for the activation of PDCs; designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. The company is developing TLD-1433, which is in Phase II for the treatment of non-muscle invasive bladder cancer (NMIBC). Its products include TLC-1000, TLC-2000, and controllerless series laser technology products for the elimination of pain, reduction of inflammation, and acceleration of tissue healing, as well as TLC-1000 and TLC-2000 accessories; and Theralase therapeutic laser treatments for patients, including pain management, arthritis, wound healing, addiction rehabilitation and weight loss, and anti-aging, as well as companion animals and equine. Theralase Technologies Inc. has a research agreement with the University of Manitoba Medical Microbiology department for the development of a coronavirus vaccine and therapy. The company sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1994 and is headquartered in Toronto, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.8Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.04 out of 5 stars

Industry, Sector and Symbol

Industry Medical Appliances & Equipment



Sales & Book Value

Annual SalesC$976,634.00
Cash FlowC$0.04 per share
Book ValueC$0.05 per share



Market CapC$38.81 million
Next Earnings Date12/4/2020 (Estimated)
0.00 (0.00 %)
(As of 11/27/2020 01:43 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TLT News and Ratings via Email

Sign-up to receive the latest news and ratings for TLT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Theralase Technologies Inc. (TLT.V) (CVE:TLT) Frequently Asked Questions

How has Theralase Technologies Inc. (TLT.V)'s stock been impacted by Coronavirus?

Theralase Technologies Inc. (TLT.V)'s stock was trading at C$0.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, TLT stock has decreased by 24.0% and is now trading at C$0.19.
View which stocks have been most impacted by COVID-19

What stocks does MarketBeat like better than Theralase Technologies Inc. (TLT.V)?

Wall Street analysts have given Theralase Technologies Inc. (TLT.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Theralase Technologies Inc. (TLT.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Theralase Technologies Inc. (TLT.V)'s next earnings date?

Theralase Technologies Inc. (TLT.V) is scheduled to release its next quarterly earnings announcement on Friday, December 4th 2020.
View our earnings forecast for Theralase Technologies Inc. (TLT.V)

Who are some of Theralase Technologies Inc. (TLT.V)'s key competitors?

What other stocks do shareholders of Theralase Technologies Inc. (TLT.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Theralase Technologies Inc. (TLT.V) investors own include IMRIS (IMRSQ), Brookfield Property Partners (BPY), Cross Timbers Royalty Trust (CRT), Aurora Cannabis Inc. (ACB.TO) (ACB), AGNC Investment (AGNC), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Ford Motor (F), Gladstone Investment (GAIN) and Heat Biologics (HTBX).

Who are Theralase Technologies Inc. (TLT.V)'s key executives?

Theralase Technologies Inc. (TLT.V)'s management team includes the following people:
  • Dr. Shawn Shirazi B.Sc., M.Sc., Ph.D., Chief Exec. Officer
  • Ms. Kristina Hachey CPA, CFO & Director
  • Dr. Arkady Mandel, Chief Scientific Officer & Director
  • Mr. David M. Groves B.A, Pres of World Trade Division
  • Mr. Roger John Dumoulin-White, Director of Bus. Devel.
  • Lori Leach, Marketing & Media Relations Consultant
  • Mr. Vaughn Wyant, Marketing & Media Relations Consultant
  • Dr. Terry Ruch DVM, Equine Medical Consultant

What is Theralase Technologies Inc. (TLT.V)'s stock symbol?

Theralase Technologies Inc. (TLT.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "TLT."

How do I buy shares of Theralase Technologies Inc. (TLT.V)?

Shares of TLT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Theralase Technologies Inc. (TLT.V)'s stock price today?

One share of TLT stock can currently be purchased for approximately C$0.19.

How big of a company is Theralase Technologies Inc. (TLT.V)?

Theralase Technologies Inc. (TLT.V) has a market capitalization of C$38.81 million and generates C$976,634.00 in revenue each year. Theralase Technologies Inc. (TLT.V) employs 20 workers across the globe.

What is Theralase Technologies Inc. (TLT.V)'s official website?

The official website for Theralase Technologies Inc. (TLT.V) is theralase.com.

How can I contact Theralase Technologies Inc. (TLT.V)?

Theralase Technologies Inc. (TLT.V)'s mailing address is 1945 Queen St E, TORONTO, ON M4L 1H7, Canada. The company can be reached via phone at +1-416-6995273.

This page was last updated on 11/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.